Table 2. Baseline characteristics of study subjects.
| Total n=83 | Plaque (-) n=21 | Plaque (+) n=62 | P-value | |
|---|---|---|---|---|
| Age | 74 (66.5–79.8) | 64.5 (55.8–72.5) | 75 (70–81) | <0.0001 |
| Male, n (%) | 41 (49.3%) | 6 (28.6%) | 35 (56.5%) | 0.014 |
| Smoking, n (%) | 11 (13.4%) | 0 (0%) | 11 (17.7%) | 0.043 |
| HbA1c | 6.2 (5.6–6.7) | 5.9 (5.5–6.6) | 6.2 (5.7–6.7) | 0.93 |
| TG | 97 (69–120) | 76 (61–103) | 101 (74–125) | 0.062 |
| HDL-C | 61 (51–71) | 71 (63–77) | 58 (49–66) | 0.006 |
| LDL-C | 103 (83.8–125) | 113 (95–142) | 101 (82–122) | 0.49 |
| AST | 22 (19–26) | 21 (19–24) | 22.5 (19–27) | 0.51 |
| ALT | 17 (14–24) | 16 (14–27) | 18 (13–23) | 0.53 |
| eGFR | 59.6 (48–71) | 70.4 (62.2–73.5) | 55.3 (45.9–69.1) | 0.028 |
| MBP | 92.5 (83.8–99.6) | 96 (81.6–102) | 92.3 (85.3–98.9) | 0.84 |
| BMI | 24.7 (21.4–27.1) | 23 (20.8–26.6) | 25 (22–27) | 0.14 |
| Hypertension, n (%) | 60 (72%) | 13 (62%) | 47 (75.8%) | 0.34 |
| Diabetes, n (%) | 42 (50.6%) | 9 (42.9) | 33 (53.2%) | 0.8 |
| Dyslipidemia, n (%) | 44 (53%) | 10 (47.6%) | 34 (54.8%) | 0.44 |
| Atrial fibrillation, n (%) | 4 (4.8%) | 0 | 4 (6.5%) | 0.32 |
| Heart failure, n (%) | 1 (1.2%) | 0 | 1 (1.6%) | 0.42 |
Continuous data were expressed as median and IQR, and categorical data as number and ratio. Mann–Whitney U test was performed for continuous data, and the Chi-square test was for categorical data.
Abbreviations: ALT, alanine aminotransferase; AST, aspartate transaminase; BMI, body mass index; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MBP, mean blood pressure; TG, triglyceride.